Orpheus Bioscience orpheusbioscience.com

Orpheus Bioscience focuses on the development of treatments for autoimmune diseases. In pursuit of this goal, the company develops the PantId, a protein-based therapeutic for the elimination of pathological immune cells and antibodies from patients. PantIds are specifically designed for each autoimmune disease, resulting in a product with fewer adverse effects than conventional immunosuppressive therapeutics.

Orpheus Bioscience focuses on the development of treatments for autoimmune diseases. In pursuit of this goal, the company develops the PantId, a protein-based therapeutic for the elimination of pathological immune cells and antibodies from patients. ...Show all

Company (Alive / Active)

All investors data 1 Investors

• Undisclosed Investors